Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice

被引:92
作者
Griffiths, RJ
Smith, MA
Roach, ML
Stock, JL
Stam, EJ
Milici, AJ
Scampoli, DN
Eskra, JD
Byrum, RS
Koller, BH
McNeish, JD
机构
[1] PFIZER INC,DIV CENT RES,DEPT CANC IMMUNOL & INFECT DIS,GROTON,CT 06340
[2] PFIZER INC,DIV CENT RES,DEPT MOL SCI,GROTON,CT 06340
[3] UNIV N CAROLINA,CURRICULUM GENET & MOL BIOL,CHAPEL HILL,NC 27599
[4] UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27599
关键词
D O I
10.1084/jem.185.6.1123
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Collagen-induced arthritis in the DBA/1 mouse is an experimental model of human rheumatoid arthritis. To examine the role of leukotrienes in the pathogenesis of this disease, we have developed embryonic stem (ES) cells from this mouse strain. Here, we report that DBA/1 mice made deficient in 5-lipoxygenase-activating protein (FLAP) by gene targeting in ES cells develop and sow normally. Zymosan-stimulated leukotriene production in the peritoneal cavity of these mice is undetectable, whereas they produce substantial amounts of prostaglandins. The inflammatory response to zymosan is reduced in FLAP-deficient mice. The severity of collagen-induced arthritis in the FLAP-deficient mice was substantially reduced when compared with wild-type or heterozygous animals: This was not due to an immunosuppressive effect, because anti-collagen antibody levels were similar in wild-type and FLAP-deficient mice. These data demonstrate that leukotrienes play an essential role in both the acute and chronic inflammatory response in mice.
引用
收藏
页码:1123 / 1129
页数:7
相关论文
共 27 条
[1]
ROLE OF LEUKOTRIENES REVEALED BY TARGETED DISRUPTION OF THE 5-LIPOXYGENASE GENE [J].
CHEN, XS ;
SHELLER, JR ;
JOHNSON, EN ;
FUNK, CD .
NATURE, 1994, 372 (6502) :179-182
[2]
LEUKOTRIENES ARE POTENT CONSTRICTORS OF HUMAN BRONCHI [J].
DAHLEN, SE ;
HEDQVIST, P ;
HAMMARSTROM, S ;
SAMUELSSON, B .
NATURE, 1980, 288 (5790) :484-486
[3]
DAUMY GO, 1986, BIOCHIM BIOPHYS ACTA, V998, P32
[4]
REQUIREMENT OF A 5-LIPOXYGENASE-ACTIVATING PROTEIN FOR LEUKOTRIENE SYNTHESIS [J].
DIXON, RAF ;
DIEHL, RE ;
OPAS, E ;
RANDS, E ;
VICKERS, PJ ;
EVANS, JF ;
GILLARD, JW ;
MILLER, DK .
NATURE, 1990, 343 (6255) :282-284
[5]
SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ANALYSIS OF LIPOXYGENASE PATHWAY PRODUCTS [J].
ESKRA, JD ;
PEREIRA, MJ ;
ERNEST, MJ .
ANALYTICAL BIOCHEMISTRY, 1986, 154 (01) :332-337
[6]
ACTIVATION OF LEUKOCYTE MOVEMENT AND DISPLACEMENT OF [H-3] LEUKOTRIENE-B4 FROM LEUKOCYTE MEMBRANE PREPARATIONS BY (12R)-HYDROXYEICO AND (12S)-HYDROXYEICOSATETRAENOIC ACID [J].
EVANS, JF ;
LEBLANC, Y ;
FITZSIMMONS, BJ ;
CHARLESON, S ;
NATHANIEL, D ;
LEVEILLE, C .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 917 (03) :406-410
[7]
LEUKOTRIENE-B, A POTENT CHEMOKINETIC AND AGGREGATING SUBSTANCE RELEASED FROM POLYMORPHONUCLEAR LEUKOCYTES [J].
FORDHUTCHINSON, AW ;
BRAY, MA ;
DOIG, MV ;
SHIPLEY, ME ;
SMITH, MJH .
NATURE, 1980, 286 (5770) :264-265
[8]
FORDHUTCHINSON AW, 1990, CRIT REV IMMUNOL, V10, P1
[9]
L-663,536 (MK-886) (3-[1-(4-CHLOROBENZYL)-3-T-BUTYL-THIO-5-ISOPROPYLINDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID), A NOVEL, ORALLY ACTIVE LEUKOTRIENE BIOSYNTHESIS INHIBITOR [J].
GILLARD, J ;
FORDHUTCHINSON, AW ;
CHAN, C ;
CHARLESON, S ;
DENIS, D ;
FOSTER, A ;
FORTIN, R ;
LEGER, S ;
MCFARLANE, CS ;
MORTON, H ;
PIECHUTA, H ;
RIENDEAU, D ;
ROUZER, CA ;
ROKACH, J ;
YOUNG, R ;
MACINTYRE, DE ;
PETERSON, L ;
BACH, T ;
EIERMANN, G ;
HOPPLE, S ;
HUMES, J ;
HUPE, L ;
LUELL, S ;
METZGER, J ;
MEURER, R ;
MILLER, DK ;
OPAS, E ;
PACHOLOK, S .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1989, 67 (05) :456-464
[10]
ALTERED INFLAMMATORY RESPONSES IN LEUKOTRIENE-DEFICIENT MICE [J].
GOULET, JL ;
SNOUWAERT, JN ;
LATOUR, AM ;
COFFMAN, TM ;
KOLLER, BH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) :12852-12856